Furthermore, we found that LEPR rs1137101 and rs1805094 variants are significantly associated with leptin, glucose, and cholesterol levels in specific populations, such as Africans and individuals with overweight/obesity, although these variants were not associated with glucose-lipid metabolism markers in the pooled meta-analyses in the overall population. This evidence concerns the gene LEP and obesity disorder.